LEADER 01477nam  2200421I  450 
001 9910708464103321
005 20161220150805.0
035   $a(CKB)4970000000020519
035   $a(OCoLC)966449674
035   $a(EXLCZ)994970000000020519
100   $a20161220d2016      ua             0
101 0 $aeng
135   $aur|||||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 10$aConfidential informants, status of the U.S. Drug Enforcement Administration's efforts to address a GAO recommendation /$fDiana Maurer
210  1$aWashington, DC :$cU.S. Government Accountability Office,$d2016.
215   $a1 online resource (6 pages)
300   $a"GAO-17-265R."
300   $a"November 30, 2016."
320   $aIncludes bibliographical references.
517   $aConfidential Informants
606   $aInformers$zUnited States
606   $aCriminal investigation$zUnited States
606   $aCriminal justice, Administration of$zUnited States
606   $aLaw enforcement$zUnited States
615  0$aInformers
615  0$aCriminal investigation
615  0$aCriminal justice, Administration of
615  0$aLaw enforcement
702   $aMaurer$b Diana
801  0$bGPO
801  1$bGPO
906   $aDOCUMENT
912   $a9910708464103321
996   $aConfidential informants, status of the U.S. Drug Enforcement Administration's efforts to address a GAO recommendation$93276355
997   $aUNINA